ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $149,000 | +181.1% | 61,209 | +166.7% | 0.00% | – |
| Q2 2020 | $53,000 | -43.6% | 22,950 | -33.2% | 0.00% | – |
| Q1 2020 | $94,000 | +91.8% | 34,362 | -17.5% | 0.00% | – |
| Q4 2019 | $49,000 | +81.5% | 41,631 | +65.0% | 0.00% | – |
| Q3 2019 | $27,000 | -30.8% | 25,233 | 0.0% | 0.00% | – |
| Q2 2019 | $39,000 | -61.0% | 25,233 | 0.0% | 0.00% | – |
| Q1 2019 | $100,000 | +49.3% | 25,233 | 0.0% | 0.00% | – |
| Q4 2018 | $67,000 | -63.8% | 25,233 | 0.0% | 0.00% | – |
| Q3 2018 | $185,000 | +4.5% | 25,233 | 0.0% | 0.00% | – |
| Q2 2018 | $177,000 | +0.6% | 25,233 | +33.3% | 0.00% | – |
| Q1 2018 | $176,000 | +23.9% | 18,935 | 0.0% | 0.00% | – |
| Q4 2017 | $142,000 | -29.7% | 18,935 | 0.0% | 0.00% | – |
| Q3 2017 | $202,000 | -6.5% | 18,935 | 0.0% | 0.00% | – |
| Q2 2017 | $216,000 | +22.0% | 18,935 | +15.3% | 0.00% | – |
| Q1 2017 | $177,000 | -5.3% | 16,420 | 0.0% | 0.00% | – |
| Q4 2016 | $187,000 | -8.3% | 16,420 | 0.0% | 0.00% | – |
| Q3 2016 | $204,000 | +9.7% | 16,420 | 0.0% | 0.00% | – |
| Q2 2016 | $186,000 | – | 16,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |